Programmed death ligand-2 (PD-L2) is a less studied ligand to PD-1 and has yet to be fully explored, especially in pancreatic ductal adenocarcinoma (PDAC). Here, PDCD1LG2 is linked to pancreatic ductal adenocarcinoma.